|
|
|
|
|
非在研适应症- |
最高研发阶段批准上市 |
|
首次获批日期1989-01-01 |
Phase II Study Using Nexalin Therapy for the Treatment of Depressive Symptoms Associated With Mild to Moderate Depression Episodes
The primary objectives of this Phase II study are to demonstrate the safety of Nexalin Therapy and to investigate the efficacy of Nexalin Therapy.
100 项与 Kalaco Scientific, Inc. 相关的临床结果
0 项与 Kalaco Scientific, Inc. 相关的专利(医药)
100 项与 Kalaco Scientific, Inc. 相关的药物交易
100 项与 Kalaco Scientific, Inc. 相关的转化医学